Analysts expect that Cutera, Inc. (NASDAQ:CUTR) will post earnings of $0.08 per share for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Cutera’s earnings. The lowest EPS estimate is $0.02 and the highest is $0.13. Cutera also posted earnings per share of $0.08 during the same quarter last year. The company is scheduled to report its next quarterly earnings report on Wednesday, November 3rd.
According to Zacks, analysts expect that Cutera will report full-year earnings of $0.58 per share for the current financial year, with EPS estimates ranging from $0.48 to $0.73. For the next fiscal year, analysts forecast that the firm will report earnings of $0.75 per share, with EPS estimates ranging from $0.50 to $0.91. Zacks’ EPS calculations are a mean average based on a survey of analysts that that provide coverage for Cutera.
Cutera (NASDAQ:CUTR) last posted its quarterly earnings results on Wednesday, August 4th. The medical device company reported $0.39 EPS for the quarter, beating the consensus estimate of ($0.10) by $0.49. The company had revenue of $58.59 million during the quarter, compared to analysts’ expectations of $50.15 million. Cutera had a return on equity of 14.36% and a net margin of 3.71%.
In related news, Director J Daniel Plants purchased 1,000 shares of Cutera stock in a transaction that occurred on Friday, August 13th. The shares were purchased at an average cost of $49.99 per share, with a total value of $49,990.00. Following the transaction, the director now owns 28,105 shares of the company’s stock, valued at approximately $1,404,968.95. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Joseph E. Whitters purchased 1,500 shares of Cutera stock in a transaction that occurred on Monday, August 9th. The shares were bought at an average cost of $53.89 per share, for a total transaction of $80,835.00. The disclosure for this purchase can be found here. Insiders bought a total of 3,500 shares of company stock worth $178,815 over the last ninety days. Corporate insiders own 2.10% of the company’s stock.
Several institutional investors and hedge funds have recently made changes to their positions in CUTR. First Light Asset Management LLC acquired a new position in shares of Cutera in the 1st quarter valued at approximately $37,386,000. RTW Investments LP acquired a new position in shares of Cutera in the 2nd quarter valued at approximately $35,342,000. Pura Vida Investments LLC acquired a new position in shares of Cutera in the 1st quarter valued at approximately $15,049,000. Bridger Management LLC acquired a new position in shares of Cutera in the 1st quarter valued at approximately $9,778,000. Finally, Paradigm Capital Management Inc. NY raised its position in shares of Cutera by 3,090.0% in the 2nd quarter. Paradigm Capital Management Inc. NY now owns 319,000 shares of the medical device company’s stock valued at $15,640,000 after purchasing an additional 309,000 shares in the last quarter.
CUTR traded up $0.54 during midday trading on Thursday, hitting $48.92. The company’s stock had a trading volume of 126,633 shares, compared to its average volume of 214,746. The company has a current ratio of 3.95, a quick ratio of 3.38 and a debt-to-equity ratio of 2.51. The firm has a market cap of $877.72 million, a P/E ratio of 135.95 and a beta of 1.63. The firm has a 50-day moving average price of $49.66 and a two-hundred day moving average price of $41.31. Cutera has a 52-week low of $17.67 and a 52-week high of $60.35.
Cutera, Inc engages in the provision of laser and energy-based aesthetic systems for practitioners. It operates through the following segments: United States, Japan, Asia excluding Japan, Europe, and Rest of the World. Its products include enlighten, excel HR, excel V+, secret Pro, Juliet, secret RF, and xeo.
Further Reading: Cash Asset Ratio
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.